U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
125551125551Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract InfectionsCompletedHas ResultsComplicated Urinary Tract InfectionDrug: CXA-101|Drug: Ceftazidimehttps://ClinicalTrials.gov/show/NCT00921024
125552125552Longitudinal Study in Perimenopausal Women With Risk Factors for AtherosclerosisActive, not recruitingNo Results AvailableAtherosclerosishttps://ClinicalTrials.gov/show/NCT00921011
125553125553Effect of Food Intake on Pharmacokinetic Profiles of Z-338CompletedNo Results AvailableHealthyDrug: Z-338https://ClinicalTrials.gov/show/NCT00920998
125554125554US Cycle Control and Blood Pressure StudyCompletedNo Results AvailableContraceptionDrug: Gestodene/EE (FC Patch Low, BAY86-5016)|Drug: Oral contraceptive (equivalent to the active treatment tablets of Levlite), 21-day blister SH D00593Ahttps://ClinicalTrials.gov/show/NCT00920985
125555125555Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant DiseasesRecruitingNo Results AvailableMetabolic Disorders|Hematologic, Immune, or Bone Marrow Disorders|Hemoglobinopathies|Non-malignant DisordersDrug: Transplant conditioning regimen of alemtuzumab, fludarabine, and melphalan|Drug: Transplant conditioning regimen of hydroxyurea, campath, fludarabine, thiotepa, & melphalan|Drug: Transplant conditioning regimen of hydroxyurea, campath, fludarabine, thiotepa, & melphalan|Drug: Transplant conditioning regimen of hydroxyurea, campath, fludarabine, thiotepa, & melphalanhttps://ClinicalTrials.gov/show/NCT00920972
125556125556Advair Pediatric Once-DailyCompletedNo Results AvailableAsthmaDrug: FP 100mcg|Drug: FSC 100/50mcg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00920959
125557125557A Safety and Efficacy Study of Dimebon in Patients With Huntington DiseaseCompletedNo Results AvailableHuntington DiseaseDrug: Dimebon|Other: Placebohttps://ClinicalTrials.gov/show/NCT00920946
125558125558Effect of AIN457 on Ozone-induced Airway Neutrophilia Compared to Placebo and Corticosteroid in Healthy SubjectsCompletedNo Results AvailableHealthyBiological: AIN457|Other: Placebo|Drug: prednisolonehttps://ClinicalTrials.gov/show/NCT00920933
125559125559An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical CancerRecruitingNo Results AvailableCervical CancerRadiation: 3D MRI-guided Brachytherapyhttps://ClinicalTrials.gov/show/NCT00920920
125560125560Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced MelanomaCompletedHas ResultsAdvanced MelanomaBiological: Ipilimumabhttps://ClinicalTrials.gov/show/NCT00920907
125561125561Effect of Plant Stanol Esters on Blood LipidsCompletedNo Results AvailableElevated Blood LipidsDietary Supplement: plant stanol esterhttps://ClinicalTrials.gov/show/NCT00920894
125562125562Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring SystemCompletedNo Results AvailableDiabetes MellitusDevice: FreeStyle Navigator Continuous Glucose Monitoring Systemhttps://ClinicalTrials.gov/show/NCT00920881
125563125563XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibCompletedNo Results AvailableSolid Tumor|Metastatic Colorectal CancerDrug: dasatinib|Drug: bevacizumab|Drug: Oxaliplatin|Drug: Capecitabinehttps://ClinicalTrials.gov/show/NCT00920868
125564125564Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaCompletedHas ResultsMultiple MyelomaDrug: bendamustine|Drug: bortezomibhttps://ClinicalTrials.gov/show/NCT00920855
125565125565Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell TransplantCompletedNo Results AvailableCardiovascular Complications|Leukemia|Long-term Effects Secondary to Cancer Therapy in Children|Metabolic Syndromehttps://ClinicalTrials.gov/show/NCT00920842
125566125566Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for AlcoholismActive, not recruitingNo Results AvailableAlcohol DependenceDrug: Drug|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00920829
125567125567Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell CancerActive, not recruitingHas ResultsKidney NeoplasmsDrug: Axitinib (AG-013736)|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT00920816
125568125568A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic MetastasesCompletedNo Results AvailableNeoplasms, Colorectal|Colorectal CancerDrug: Placebo|Drug: SRT501https://ClinicalTrials.gov/show/NCT00920803
125569125569Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphomaCompletedHas ResultsAdult T-cell Leukemia-lymphomaBiological: KW-0761https://ClinicalTrials.gov/show/NCT00920790
125570125570Survey and Cognitive Behavior Therapy for Chronic Fatigue Syndrome/Myalgic EncephalomyelitisCompletedNo Results AvailableChronic Fatigue Syndrome|Myalgic Encephalomyelitis|Fatigue|PainBehavioral: CBT|Behavioral: CBT|Behavioral: Control grouphttps://ClinicalTrials.gov/show/NCT00920777
125571125571A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System InhibitorsCompletedNo Results AvailableChronic Kidney Disease|Diabetic NephropathyDrug: Placebo for Atrasentan 0.2 mg/mL solution|Drug: 0.25 mg Atrasentan QD|Drug: 0.75 mg Atrasentan QD|Drug: 1.75 mg Atrasentan QDhttps://ClinicalTrials.gov/show/NCT00920764
125572125572Comparison of on Demand Sedation With Study Method Versus on Demand Sedation With Conventional Method for Performing Colonoscopy for Colorectal Cancer Screening and SurveillanceRecruitingNo Results AvailableColorectal Cancer ScreeningProcedure: Water infusion|Procedure: Air insufflationhttps://ClinicalTrials.gov/show/NCT00920751
125573125573Metabolic Syndrome in Childhood Cancer SurvivorsCompletedNo Results AvailableBrain and Central Nervous System Tumors|Leukemia|Lymphoma|Metabolic Syndrome|SarcomaOther: metabolic assessment|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT00920738
125574125574Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKACompletedNo Results AvailableDiabetic KetoacidosisDrug: Insulin (Aspart Insulin [Novolog], Regular Insulin)https://ClinicalTrials.gov/show/NCT00920725
125575125575Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic GastritisRecruitingNo Results AvailableGastritisDrug: Weiqi decotionhttps://ClinicalTrials.gov/show/NCT00920712
125576125576Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)Active, not recruitingNo Results AvailableHuntington's DiseaseDrug: CoQ10https://ClinicalTrials.gov/show/NCT00920699
125577125577Study of NXN 188 for the Treatment of Migraine With AuraCompletedHas ResultsMigraine With AuraDrug: NXN-188|Drug: placebo|Drug: sumatriptan succinatehttps://ClinicalTrials.gov/show/NCT00920686
125578125578Age Influence on the Modifications of the Oral, Pharyngeal and Laryngeal Axis Alignment in Children Induced by Head Extension: an MRI StudyCompletedNo Results AvailableHead Extension on the Anatomic Axes of the Superior AirwayProcedure: MRIhttps://ClinicalTrials.gov/show/NCT00920673
125579125579Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy VolunteersCompletedNo Results AvailablePulmonary Disease, Chronic Obstructive|Healthy VolunteerDrug: Placebo|Drug: 0.25g SRT2104|Drug: Prednisolone|Drug: 0.5g SRT2104|Drug: 1g SRT2104|Drug: 2g SRT2104https://ClinicalTrials.gov/show/NCT00920660
125580125580A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®CompletedHas ResultsHunter SyndromeOther: Control|Drug: Idursulfase IT (1 mg)|Drug: Idursulfase IT (10 mg)|Drug: Idursulfase IT (30 mg)https://ClinicalTrials.gov/show/NCT00920647

* Görseller ve İçerik tekif hakkına sahip olabilir